comparemela.com
Home
Live Updates
Medivir have agreed with Lonza to manufacture a fostrox GMP
Medivir have agreed with Lonza to manufacture a fostrox GMP
Medivir have agreed with Lonza to manufacture a fostrox GMP campaign, to be tested in 2L HCC with intent to commercialize via accelerated approval
/PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet...
Related Keywords
Stockholm ,
Sweden ,
Magnus Christensen ,
Jens Lindberg ,
,
Nasdaq Stockholm ,
Small Cap ,
Medivir ,